首页|Rifaximin for the prevention of spontaneous bacterial peritonitis

Rifaximin for the prevention of spontaneous bacterial peritonitis

扫码查看
According to a review article by Biecker etal published in a previous issue of World Journal of Gastroenterology in March 2011,intestinal decontamination with norfloxacin remains the mainstay of primary prophylaxis of spontaneous bacterial peritonitis (SBP) at the expense of development of quinolone-resistant bacteria after long-term use.In our research,the administration of a 4-wk regimen with rifaximin 1200 mg/d reduced significantly the ascitic neutrophil count in cirrhotic patients with sterile ascites in line with a significant decrease in plasma endotoxin levels.Our observations concur with recent findings,showing a significantly reduced 5-year probability of SBP in cirrhotic patients taking rifaximin.

RifaximinCirrhosisAscitesSpontaneous bacterial peritonitis

Georgios N Kalambokis、Athanasia Mouzaki、Maria Rodi、Epameinondas V Tsianos

展开 >

The First Division of Internal Medicine and Hepato-Gastroenterology Unit, Medical School of Ioannina, 45110 Ioannina, Greece

Division of Hematology, Department of Internal Medicine, Medical School, 26504 Patras,Greece

2012

世界胃肠病学杂志(英文版)
太原消化病研治中心

世界胃肠病学杂志(英文版)

SCI
影响因子:1.001
ISSN:1007-9327
年,卷(期):2012.18(14)
  • 2
  • 5